Trial Profile
Open label and single cohort study of edaravon on Muro disease (amyotrophic lateral sclerosis and parkinsonism-dementia complex :Kii ALS/PDC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Edaravone (Primary)
- Indications Amyotrophic lateral sclerosis; Dementia; Parkinsonian disorders
- Focus Therapeutic Use
- 23 Aug 2011 New trial record